APO Research
Talk to an analyst

APO RESEARCH · REPORT

Live Attenuated Japanese Encephalitis Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Live Attenuated Japanese Encephalitis Vaccine Industry Growth and Trends Forecast to 2032

22 December 2025101 pages

Choose your research edition.

Industry ResearchLive Attenuated Japanese Encephalitis Vaccine Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Live Attenuated Japanese Encephalitis Vaccine Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Live Attenuated Japanese Encephalitis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Live Attenuated Japanese Encephalitis Vaccine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Live Attenuated Japanese Encephalitis Vaccine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Live Attenuated Japanese Encephalitis Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Live Attenuated Japanese Encephalitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Live Attenuated Japanese Encephalitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Live Attenuated Japanese Encephalitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Live Attenuated Japanese Encephalitis Vaccine include Wuhan Institute of Biological Products, Sanofi, Novartis, Lanzhou Institute of Biological Products, Chengdu Institute of Biological Products, Cheng Da Biology, Beijing Temple of Heaven Biological Products, Valneva and Glovax Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Live Attenuated Japanese Encephalitis Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Live Attenuated Japanese Encephalitis Vaccine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Live Attenuated Japanese Encephalitis Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Live Attenuated Japanese Encephalitis Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Live Attenuated Japanese Encephalitis Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Live Attenuated Japanese Encephalitis Vaccine Market by Company

Wuhan Institute of Biological Products

Sanofi

Novartis

Lanzhou Institute of Biological Products

Chengdu Institute of Biological Products

Cheng Da Biology

Beijing Temple of Heaven Biological Products

Valneva

Glovax Co., Ltd.

Biocelect Pty Ltd

Bharat Biotech

Live Attenuated Japanese Encephalitis Vaccine Segment by Type

2.5ml

1ml

0.5ml

Live Attenuated Japanese Encephalitis Vaccine Segment by Application

Hospital

Clinic

Live Attenuated Japanese Encephalitis Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Live Attenuated Japanese Encephalitis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Live Attenuated Japanese Encephalitis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Live Attenuated Japanese Encephalitis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Live Attenuated Japanese Encephalitis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Live Attenuated Japanese Encephalitis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 2.5ml Table 2. Major Company of 1ml Table 3. Major Company of 0.5ml Table 4. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021-2026) & (k units) Table 6. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Value by Type (2021-2026) Table 9. Global Live Attenuated Japanese Encephalitis Vaccine Price by Type (2021-2026) & (US$/unit) Table 10. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2027-2032) & (k units) Table 11. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Value by Type (2027-2032) Table 14. Global Live Attenuated Japanese Encephalitis Vaccine Price by Type (2027-2032) & (US$/unit) Table 15. North America Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021-2026) & (k units) Table 16. North America Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021-2026) & (k units) Table 18. Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021-2026) & (k units) Table 22. Latin America Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 25. Live Attenuated Japanese Encephalitis Vaccine Industry Trends Table 26. Live Attenuated Japanese Encephalitis Vaccine Industry Drivers Table 27. Live Attenuated Japanese Encephalitis Vaccine Industry Opportunities and Challenges Table 28. Live Attenuated Japanese Encephalitis Vaccine Industry Restraints Table 29. Global Live Attenuated Japanese Encephalitis Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Company (2021-2026) Table 31. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Company (2021-2026) & (k units) Table 32. Global Live Attenuated Japanese Encephalitis Vaccine Sales Share by Company (2021-2026) Table 33. Global Live Attenuated Japanese Encephalitis Vaccine Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Live Attenuated Japanese Encephalitis Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Live Attenuated Japanese Encephalitis Vaccine Major Company Production Sites and Headquarters Table 36. Global Live Attenuated Japanese Encephalitis Vaccine Company, Product Type & Application Table 37. Global Live Attenuated Japanese Encephalitis Vaccine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Live Attenuated Japanese Encephalitis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Live Attenuated Japanese Encephalitis Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Region (2021-2026) & (k units) Table 42. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Value by Region (2021-2026) Table 45. Global Live Attenuated Japanese Encephalitis Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Region (2027-2032) & (k units) Table 47. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Value by Region (2027-2032) Table 50. Global Live Attenuated Japanese Encephalitis Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021-2026) & (k units) Table 53. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Value by Application (2021-2026) Table 56. Global Live Attenuated Japanese Encephalitis Vaccine Price by Application (2021-2026) & (US$/unit) Table 57. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2027-2032) & (k units) Table 58. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Value by Application (2027-2032) Table 61. Global Live Attenuated Japanese Encephalitis Vaccine Price by Application (2027-2032) & (US$/unit) Table 62. North America Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021-2026) & (k units) Table 63. North America Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021-2026) & (k units) Table 65. Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021-2026) & (k units) Table 69. Latin America Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 72. Wuhan Institute of Biological Products Company Information Table 73. Wuhan Institute of Biological Products Business Overview Table 74. Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolio Table 76. Wuhan Institute of Biological Products Recent Development Table 77. Sanofi Company Information Table 78. Sanofi Business Overview Table 79. Sanofi Live Attenuated Japanese Encephalitis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Sanofi Live Attenuated Japanese Encephalitis Vaccine Product Portfolio Table 81. Sanofi Recent Development Table 82. Novartis Company Information Table 83. Novartis Business Overview Table 84. Novartis Live Attenuated Japanese Encephalitis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Novartis Live Attenuated Japanese Encephalitis Vaccine Product Portfolio Table 86. Novartis Recent Development Table 87. Lanzhou Institute of Biological Products Company Information Table 88. Lanzhou Institute of Biological Products Business Overview Table 89. Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolio Table 91. Lanzhou Institute of Biological Products Recent Development Table 92. Chengdu Institute of Biological Products Company Information Table 93. Chengdu Institute of Biological Products Business Overview Table 94. Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolio Table 96. Chengdu Institute of Biological Products Recent Development Table 97. Cheng Da Biology Company Information Table 98. Cheng Da Biology Business Overview Table 99. Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Product Portfolio Table 101. Cheng Da Biology Recent Development Table 102. Beijing Temple of Heaven Biological Products Company Information Table 103. Beijing Temple of Heaven Biological Products Business Overview Table 104. Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolio Table 106. Beijing Temple of Heaven Biological Products Recent Development Table 107. Valneva Company Information Table 108. Valneva Business Overview Table 109. Valneva Live Attenuated Japanese Encephalitis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Valneva Live Attenuated Japanese Encephalitis Vaccine Product Portfolio Table 111. Valneva Recent Development Table 112. Glovax Co., Ltd. Company Information Table 113. Glovax Co., Ltd. Business Overview Table 114. Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Product Portfolio Table 116. Glovax Co., Ltd. Recent Development Table 117. Biocelect Pty Ltd Company Information Table 118. Biocelect Pty Ltd Business Overview Table 119. Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Product Portfolio Table 121. Biocelect Pty Ltd Recent Development Table 122. Bharat Biotech Company Information Table 123. Bharat Biotech Business Overview Table 124. Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Product Portfolio Table 126. Bharat Biotech Recent Development Table 127. North America Live Attenuated Japanese Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 128. North America Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2021-2026) & (k units) Table 129. North America Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Country (2021-2026) Table 130. North America Live Attenuated Japanese Encephalitis Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 131. North America Live Attenuated Japanese Encephalitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 132. North America Live Attenuated Japanese Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Live Attenuated Japanese Encephalitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Live Attenuated Japanese Encephalitis Vaccine Market Share by Country (2021-2026) Table 135. North America Live Attenuated Japanese Encephalitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Live Attenuated Japanese Encephalitis Vaccine Market Share Forecast by Country (2027-2032) Table 137. Europe Live Attenuated Japanese Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 138. Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2021-2026) & (k units) Table 139. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Country (2021-2026) Table 140. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 141. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Live Attenuated Japanese Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Live Attenuated Japanese Encephalitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Live Attenuated Japanese Encephalitis Vaccine Market Share by Country (2021-2026) Table 145. Europe Live Attenuated Japanese Encephalitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Live Attenuated Japanese Encephalitis Vaccine Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2021-2026) & (k units) Table 149. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 151. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Market Share by Country (2021-2026) Table 155. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Market Share Forecast by Country (2027-2032) Table 157. Latin America Live Attenuated Japanese Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 158. Latin America Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2021-2026) & (k units) Table 159. Latin America Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Country (2021-2026) Table 160. Latin America Live Attenuated Japanese Encephalitis Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 161. Latin America Live Attenuated Japanese Encephalitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Live Attenuated Japanese Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Live Attenuated Japanese Encephalitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Live Attenuated Japanese Encephalitis Vaccine Market Share by Country (2021-2026) Table 165. Latin America Live Attenuated Japanese Encephalitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Live Attenuated Japanese Encephalitis Vaccine Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2021-2026) & (k units) Table 169. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 171. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Market Share by Country (2021-2026) Table 175. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Live Attenuated Japanese Encephalitis Vaccine Distributors List Table 180. Live Attenuated Japanese Encephalitis Vaccine Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Live Attenuated Japanese Encephalitis Vaccine Image Figure 2. Global Live Attenuated Japanese Encephalitis Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Live Attenuated Japanese Encephalitis Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Live Attenuated Japanese Encephalitis Vaccine Sales (2021-2032) & (k units) Figure 5. 2.5ml Image Figure 6. Global 2.5ml Sales YoY Growth (2021-2032) & (k units) Figure 7. 1ml Image Figure 8. Global 1ml Sales YoY Growth (2021-2032) & (k units) Figure 9. 0.5ml Image Figure 10. Global 0.5ml Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Live Attenuated Japanese Encephalitis Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Live Attenuated Japanese Encephalitis Vaccine Market Share by Type 2025 VS 2032 Figure 13. North America Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. North America Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Live Attenuated Japanese Encephalitis Vaccine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Live Attenuated Japanese Encephalitis Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Live Attenuated Japanese Encephalitis Vaccine Market Share by Application 2025 VS 2032 Figure 31. North America Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. North America Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales Market Share in Value by Application in 2025 Figure 41. North America Live Attenuated Japanese Encephalitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Live Attenuated Japanese Encephalitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Live Attenuated Japanese Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Live Attenuated Japanese Encephalitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Live Attenuated Japanese Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Live Attenuated Japanese Encephalitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Live Attenuated Japanese Encephalitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Live Attenuated Japanese Encephalitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Live Attenuated Japanese Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Live Attenuated Japanese Encephalitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Live Attenuated Japanese Encephalitis Vaccine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Live Attenuated Japanese Encephalitis Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 2.5ml
  • 1ml
  • 0.5ml
Applications
  • Hospital
  • Clinic
Companies covered
  • Wuhan Institute of Biological Products
  • Sanofi
  • Novartis
  • Lanzhou Institute of Biological Products
  • Chengdu Institute of Biological Products
  • Cheng Da Biology
  • Beijing Temple of Heaven Biological Products
  • Valneva
  • Glovax Co., Ltd.
  • Biocelect Pty Ltd
  • Bharat Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Live Attenuated Japanese Encephalitis Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Live Attenuated Japanese Encephalitis Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Live Attenuated Japanese Encephalitis Vaccine Market by Type
  6. 1.3.1 2.5ml
  7. 1.3.2 1ml
  8. 1.3.3 0.5ml
  9. 1.4 Global Live Attenuated Japanese Encephalitis Vaccine Market Size by Type
  10. 1.4.1 Global Live Attenuated Japanese Encephalitis Vaccine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Live Attenuated Japanese Encephalitis Vaccine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Live Attenuated Japanese Encephalitis Vaccine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Live Attenuated Japanese Encephalitis Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Live Attenuated Japanese Encephalitis Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Live Attenuated Japanese Encephalitis Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Live Attenuated Japanese Encephalitis Vaccine Industry Trends
  2. 2.2 Live Attenuated Japanese Encephalitis Vaccine Industry Drivers
  3. 2.3 Live Attenuated Japanese Encephalitis Vaccine Industry Opportunities and Challenges
  4. 2.4 Live Attenuated Japanese Encephalitis Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Live Attenuated Japanese Encephalitis Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Live Attenuated Japanese Encephalitis Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Live Attenuated Japanese Encephalitis Vaccine Price (2021-2026)
  4. 3.4 Global Live Attenuated Japanese Encephalitis Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Live Attenuated Japanese Encephalitis Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Live Attenuated Japanese Encephalitis Vaccine Company, Product Type & Application
  7. 3.7 Global Live Attenuated Japanese Encephalitis Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Live Attenuated Japanese Encephalitis Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Live Attenuated Japanese Encephalitis Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Live Attenuated Japanese Encephalitis Vaccine Tier 1, Tier 2, and Tier 3
4 Live Attenuated Japanese Encephalitis Vaccine Regional Status and Outlook
  1. 4.1 Global Live Attenuated Japanese Encephalitis Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Live Attenuated Japanese Encephalitis Vaccine Historic Market Size by Region
  3. 4.2.1 Global Live Attenuated Japanese Encephalitis Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Live Attenuated Japanese Encephalitis Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Live Attenuated Japanese Encephalitis Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Live Attenuated Japanese Encephalitis Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Live Attenuated Japanese Encephalitis Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Live Attenuated Japanese Encephalitis Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Live Attenuated Japanese Encephalitis Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Live Attenuated Japanese Encephalitis Vaccine by Application
  1. 5.1 Live Attenuated Japanese Encephalitis Vaccine Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Live Attenuated Japanese Encephalitis Vaccine Market Size by Application
  5. 5.2.1 Global Live Attenuated Japanese Encephalitis Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Live Attenuated Japanese Encephalitis Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Live Attenuated Japanese Encephalitis Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Live Attenuated Japanese Encephalitis Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Live Attenuated Japanese Encephalitis Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Live Attenuated Japanese Encephalitis Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Wuhan Institute of Biological Products
  2. 6.1.1 Wuhan Institute of Biological Products Company Information
  3. 6.1.2 Wuhan Institute of Biological Products Business Overview
  4. 6.1.3 Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
  6. 6.1.5 Wuhan Institute of Biological Products Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Lanzhou Institute of Biological Products
  20. 6.4.1 Lanzhou Institute of Biological Products Company Information
  21. 6.4.2 Lanzhou Institute of Biological Products Business Overview
  22. 6.4.3 Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
  24. 6.4.5 Lanzhou Institute of Biological Products Recent Developments
  25. 6.5 Chengdu Institute of Biological Products
  26. 6.5.1 Chengdu Institute of Biological Products Company Information
  27. 6.5.2 Chengdu Institute of Biological Products Business Overview
  28. 6.5.3 Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
  30. 6.5.5 Chengdu Institute of Biological Products Recent Developments
  31. 6.6 Cheng Da Biology
  32. 6.6.1 Cheng Da Biology Company Information
  33. 6.6.2 Cheng Da Biology Business Overview
  34. 6.6.3 Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
  36. 6.6.5 Cheng Da Biology Recent Developments
  37. 6.7 Beijing Temple of Heaven Biological Products
  38. 6.7.1 Beijing Temple of Heaven Biological Products Company Information
  39. 6.7.2 Beijing Temple of Heaven Biological Products Business Overview
  40. 6.7.3 Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
  42. 6.7.5 Beijing Temple of Heaven Biological Products Recent Developments
  43. 6.8 Valneva
  44. 6.8.1 Valneva Company Information
  45. 6.8.2 Valneva Business Overview
  46. 6.8.3 Valneva Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Valneva Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
  48. 6.8.5 Valneva Recent Developments
  49. 6.9 Glovax Co., Ltd.
  50. 6.9.1 Glovax Co., Ltd. Company Information
  51. 6.9.2 Glovax Co., Ltd. Business Overview
  52. 6.9.3 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
  54. 6.9.5 Glovax Co., Ltd. Recent Developments
  55. 6.10 Biocelect Pty Ltd
  56. 6.10.1 Biocelect Pty Ltd Company Information
  57. 6.10.2 Biocelect Pty Ltd Business Overview
  58. 6.10.3 Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
  60. 6.10.5 Biocelect Pty Ltd Recent Developments
  61. 6.11 Bharat Biotech
  62. 6.11.1 Bharat Biotech Company Information
  63. 6.11.2 Bharat Biotech Business Overview
  64. 6.11.3 Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Product Portfolio
  66. 6.11.5 Bharat Biotech Recent Developments
7 North America by Country
  1. 7.1 North America Live Attenuated Japanese Encephalitis Vaccine Sales by Country
  2. 7.1.1 North America Live Attenuated Japanese Encephalitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Live Attenuated Japanese Encephalitis Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Live Attenuated Japanese Encephalitis Vaccine Market Size by Country
  6. 7.2.1 North America Live Attenuated Japanese Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Live Attenuated Japanese Encephalitis Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Live Attenuated Japanese Encephalitis Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Country
  2. 8.1.1 Europe Live Attenuated Japanese Encephalitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Live Attenuated Japanese Encephalitis Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Live Attenuated Japanese Encephalitis Vaccine Market Size by Country
  6. 8.2.1 Europe Live Attenuated Japanese Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Live Attenuated Japanese Encephalitis Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Live Attenuated Japanese Encephalitis Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Live Attenuated Japanese Encephalitis Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Live Attenuated Japanese Encephalitis Vaccine Sales by Country
  2. 10.1.1 South America Live Attenuated Japanese Encephalitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Live Attenuated Japanese Encephalitis Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Live Attenuated Japanese Encephalitis Vaccine Market Size by Country
  6. 10.2.1 South America Live Attenuated Japanese Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Live Attenuated Japanese Encephalitis Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Live Attenuated Japanese Encephalitis Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Live Attenuated Japanese Encephalitis Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Live Attenuated Japanese Encephalitis Vaccine Value Chain Analysis
  2. 12.1.1 Live Attenuated Japanese Encephalitis Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Live Attenuated Japanese Encephalitis Vaccine Production Mode & Process
  7. 12.2 Live Attenuated Japanese Encephalitis Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Live Attenuated Japanese Encephalitis Vaccine Distributors
  10. 12.2.3 Live Attenuated Japanese Encephalitis Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst